keyword
https://read.qxmd.com/read/38711358/circulating-tumor-dna-and-cancer-tissue-based-next-generation-sequencing-reveals-comparable-consistency-in-targeted-gene-mutations-for-advanced-or-metastatic-non-small-cell-lung-cancer
#21
JOURNAL ARTICLE
Weijia Huang, Kai Xu, Zhenkun Liu, Yifeng Wang, Zijia Chen, Yanyun Gao, Renwang Peng, Qinghua Zhou
BACKGROUND: Molecular subtyping is an essential complementarity after pathological analyses for targeted therapy. This study aimed to investigate the consistency of next-generation sequencing (NGS) results between circulating tumor DNA (ctDNA)-based and tissue-based in non-small cell lung cancer (NSCLC) and identify the patient characteristics that favor ctDNA testing. METHODS: Patients who diagnosed with NSCLC and received both ctDNA- and cancer tissue-based NGS before surgery or systemic treatment in Lung Cancer Center, Sichuan University West China Hospital between December 2017 and August 2022 were enrolled...
May 6, 2024: Chinese Medical Journal
https://read.qxmd.com/read/38711021/whole-genome-sequence-analysis-of-shallot-virus-x-from-india-reveals-it-to-be-a-natural-recombinant-with-positive-selection-pressure
#22
JOURNAL ARTICLE
Jyoti Singh, Sachin Teotia, Ajay Kumar Singh, Meenakshi Arya, Ajaya Kumar Rout, Bijay Kumar Behera, Shahana Majumder
BACKGROUND: Shallots are infected by various viruses like Onion yellow dwarf virus (OYDV), Leek yellow stripe virus (LYSV), Shallot latent virus (SLV) and Shallot virus X (ShVX). In India, they have been found to be persistently infected by ShVX. ShVX also infects onion and garlic in combination with other carlaviruses and potyviruses. ShVX is a member of genus Allexivirus of family Alphaflexiviridae. ShVX has a monopartite genome, which is represented by positive sense single-stranded RNA...
May 6, 2024: BMC genomic data
https://read.qxmd.com/read/38710292/comparative-analysis-of-mitochondrial-genomes-in-ceratocystis-fimbriata-complex-across-diverse-hosts
#23
JOURNAL ARTICLE
Samsuddin Ahmad Syazwan, Ahmad Mohd-Farid, Shiou Yih Lee, Rozi Mohamed
The decline ofAcacia mangiumWilld. in Malaysia, especially in Sabah since 2010, is primarily due toCeratocystiswilt and canker disease (CWCD) caused by theCeratocystis fimbriataEllis & Halst. complex. This study was aimed to investigate the mitochondrial genome architecture of two differentC. fimbriatacomplex isolates from Malaysia: one fromA. mangiumin Pahang (FRIM1162) and another fromEucalyptus pellitain Sarawak (FRIM1441). This research employed Next- Generation Sequencing (NGS) to contrast genomes from diverse hosts with nine additional mitochondrial sequences, identifying significant genetic diversity and mutational hotspots in the mitochondrial genome alignment...
May 4, 2024: Gene
https://read.qxmd.com/read/38709224/exploring-the-clinical-utility-of-exome-sequencing-mono-duo-trio-in-prenatal-testing-a-retrospective-study-in-a-tertiary-care-centre-in-south-india
#24
JOURNAL ARTICLE
Hemalatha Ilangovan, Janane Elangovan, Sumita Danda, Manisha M Beck, Preethi Navaneethan, Rekha Athiyarath
OBJECTIVES: With the availability of Next Generation Sequencing (NGS) diagnosis of genetic disorders has improved significantly. Its use is also applicable to ascertain diagnosis and management in a perinatal setting. The study aims to detect the genetic aetiology of various congenital structural and functional defects using NGS technology in the reproductive cohort at a tertiary centre. The secondary objective is to address challenges in the interpretation of variants. METHODS: This was a retrospective study of couples who underwent exome sequencing (Mono-testing proband only or Duo-testing parents only or Trio-testing proband and parents) for suspected single gene disorders between years 2020-2022 at a tertiary care perinatal center in the South India ...
May 7, 2024: Journal of Perinatal Medicine
https://read.qxmd.com/read/38708901/revolutionizing-personalized-cancer-treatment-the-synergy-of-next-generation-sequencing-and-crispr-cas9
#25
REVIEW
Muniba Mahmood, Izza Taufiq, Sana Mazhar, Faiqa Hafeez, Kausar Malik, Samia Afzal
In the context of cancer heterogeneity, the synergistic action of next-generation sequencing (NGS) and CRISPR/Cas9 plays a promising role in the personalized treatment of cancer. NGS enables high-throughput genomic profiling of tumors and pinpoints specific mutations that primarily lead to cancer. Oncologists use this information obtained from NGS in the form of DNA profiling or RNA analysis to tailor precision strategies based on an individual's unique molecular signature. Furthermore, the CRISPR technique enables precise editing of cancer-specific mutations, allowing targeted gene modifications...
May 6, 2024: Personalized Medicine
https://read.qxmd.com/read/38708170/detection-of-13-novel-variants-and-investigation-of-mutation-distribution-by-next-generation-sequencing-in-hemoglobinopathies-a-single-center-experience
#26
JOURNAL ARTICLE
Ozge Ozalp, Ozlem Anlas
Hemoglobinopathies are the most common monogenic disorders in the world. Traditional diagnostic algorithms generated by conventional methods for thalassemia can be labor-intensive and time-consuming due to the complexities of the genes involved and the variability in disease-causing mutations. With the advantages of next-generation sequencing (NGS) technology, molecular analysis of highly complex diseases such as hemoglobinopathies has become easier. Next-generation sequencing is a highly sensitive and effective method due to its capacity to sequence many gene regions simultaneously while allowing good read depths...
April 2024: Indian Journal of Hematology & Blood Transfusion
https://read.qxmd.com/read/38707821/description-of-a-new-simple-and%C3%A2-cost-effective-molecular-testing-that-could-simplify-muc1-variant-detection
#27
JOURNAL ARTICLE
Victor Fages, Florentin Bourre, Romain Larrue, Andrea Wenzel, Jean-Baptiste Gibier, Fabrice Bonte, Claire-Marie Dhaenens, Kendrah Kidd, Stanislav Kmoch, Anthony Bleyer, François Glowacki, Olivier Grunewald
INTRODUCTION: Patients with autosomal dominant tubulointerstitial kidney disease (ADTKD) usually present with nonspecific progressive chronic kidney disease (CKD) with mild to negative proteinuria and a family history. ADTKD- MUC1 leads to the formation of a frameshift protein that accumulates in the cytoplasm, leading to tubulointerstitial damage. ADTKD- MUC1 prevalence remains unclear because MUC1 variants are not routinely detected by standard next-generation sequencing (NGS) techniques...
May 2024: KI Reports
https://read.qxmd.com/read/38706599/case-report-systemic-presentation-of-alk-positive-histiocytosis
#28
Yongbao Wei, Ruochen Zhang, Deng Lin, Xiaoyan Chen, Lizhi Li, Haijian Huang
ALK-positive Histiocytosis (ALK-HSs) is a recently identified rare clinical entity characterized by tissue histiocytic alterations associated with ALK gene rearrangement. Clinical presentations can be solitary, multifocal, or systemic (involving multiple sites and organs). Due to limited reported cases, there is inadequate understanding of this disease. This report presents a case of ALK-HSs in a 71-year-old male patient who presented with hematuria for one week. Imaging studies conducted at an external hospital showed multiple lesions in the penis, bilateral testes, back skin, and the third lumbar vertebra...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38706592/case-report-the-effect-of-second-line-vebreltinib-treatment-on-a-patient-with-advanced-nsclc-harboring-the-met-exon-14-skipping-mutation-after-tepotinib-treatment
#29
Siyuan Huang, Linlin Li, Ningning Yan, Huixian Zhang, Qianqian Guo, Sanxing Guo, Di Geng, Xincheng Liu, Xingya Li
BACKGROUND: Highly selective type Ib mesenchymal-epithelial transition gene (MET) tyrosine kinase inhibitors (TKIs) are the standard-of-care (SOC) therapy for previously untreated non-small cell lung cancer (NSCLC) harboring MET exon 14 (METex14) skipping mutations. However, there are rare reports describing effective regimens for patients who fail SOC without identifying resistant mutations or tissue transformation. CASE REPORT: We report the first case of a 74-year-old woman with lung adenocarcinoma (cT1cNxM0) harboring METex14 splice region mutation, which was identified by a next-generation sequencing (NGS)-based assay...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38706128/two-new-hla-dqb1-03-02-01-variants-with-substitutions-in-intron-2-hla-dqb1-03-02-01-19-and-dqb1-03-02-01-21
#30
JOURNAL ARTICLE
Francisco Javier Gil-Etayo, Daniel Arroyo-Sánchez, Jairo Eduardo Niño Ramírez, Ariadna Vicente Parra, Amalia Tejeda Velarde
Two different single nucleotide substitutions in intron 2 give rise to novel HLA-DQB1*03:02:01 alleles.
May 2024: HLA
https://read.qxmd.com/read/38705589/redefining-the-bacteriophage-mv4-site-specific-recombination-system-and-the-sequence-specificity-of-its-attb-and-core-attp-sites
#31
JOURNAL ARTICLE
Kevin Debatisse, Pierre Lopez, Maryse Poli, Philippe Rousseau, Manuel Campos, Michèle Coddeville, Muriel Cocaign-Bousquet, Pascal Le Bourgeois
Through their involvement in the integration and excision of a large number of mobile genetic elements, such as phages and integrative and conjugative elements (ICEs), site-specific recombination systems based on heterobivalent tyrosine recombinases play a major role in genome dynamics and evolution. However, despite hundreds of these systems having been identified in genome databases, very few have been described in detail, with none from phages that infect Bacillota (formerly Firmicutes). In this study, we reanalyzed the recombination module of Lactobacillus delbrueckii subsp...
May 5, 2024: Molecular Microbiology
https://read.qxmd.com/read/38705444/circulating-mirna-and-circulating-tumor-dna-application-as-liquid-biopsy-markers-in-gastric-cancer
#32
REVIEW
Farhad Shaker, Sepideh Razi, Nima Rezaei
Liquid biopsy has been investigated as a novel method to overcome the numerous challenges in gastric cancer (GC) management. This non-invasive, feasible, and easy-to-repeat method has been shown to be cost-effective and capable of increasing diagnostic sensitivity and prognostic assessment. Additionally, it is potentially accurate to aid decision-making and personalized treatment planning. MicroRNA (miRNA) and circulating tumor DNA (ctDNA) markers can enhance GC management in various aspects, including diagnosis (mainly earlier diagnosis and the ability to perform population-based screening), prognosis (more precise stratification of prognosis), and treatment (including more accurate prediction of treatment response and earlier detection of resistance to the treatment)...
May 3, 2024: Clinical Biochemistry
https://read.qxmd.com/read/38704795/rapid-diagnosis-of-pneumocystis-jirovecii-pneumonia-and-respiratory-tract-colonization-by-next-generation-sequencing
#33
JOURNAL ARTICLE
Fanfan Xing, Chaowen Deng, Zhendong Luo, Shan Zou, Min Liu, Haiyan Ye, Linlin Sun, Chi-Ching Tsang, Simon K F Lo, Susanna K P Lau, Patrick C Y Woo
OBJECTIVES: To describe the epidemiology of Pneumocystis jirovecii pneumonia and colonization diagnosed by next-generation sequencing (NGS) and explore the usefulness of the number of P. jirovecii sequence reads for the diagnosis of P. jirovecii pneumonia. METHODS: We examined the NGS results for P. jirovecii in respiratory samples collected from patients and analysed their clinical, radiological and microbiological characteristics. RESULTS: Among 285 respiratory samples collected over a 12-month period (January to December 2022), P...
May 5, 2024: Mycopathologia
https://read.qxmd.com/read/38704351/pleural-effusion-supernatant-a-reliable-resource-for-cell-free-dna-in-molecular-testing-of-lung-cancer
#34
JOURNAL ARTICLE
Shilpi Thakur, Amber Rathor, Surabhi Jain, Aruna Nambirajan, Sachin Khurana, Prabhat Singh Malik, Deepali Jain
INTRODUCTION: DNA extracted from malignant pleural effusion (PE) sediments is the traditional source of tumor DNA for predictive biomarker molecular testing (MT). Few recent studies have proposed the utility of cell-free DNA (cfDNA) extracted from effusion cytology centrifuged supernatants (CCS) in MT. The aim of this study was to assess the feasibility and utility of molecular testing on cfDNA extracted from PE CCS in lung cancer patients. METHOD: The study was of prospective design...
March 29, 2024: Journal of the American Society of Cytopathology
https://read.qxmd.com/read/38704094/different-reference-genomes-determine-different-results-comparing-snp-calling-in-rad-seq-of-engelhardia-roxburghiana-using-different-reference-genomes
#35
JOURNAL ARTICLE
Pei-Han Huang, Tian-Rui Wang, Min Li, Ou-Yan Fang, Ren-Ping Su, Hong-Hu Meng, Yi-Gang Song, Jie Li
Advances in next-generation sequencing (NGS) have significantly reduced the cost and improved the efficiency of obtaining single nucleotide polymorphism (SNP) markers, particularly through restriction site-associated DNA sequencing (RAD-seq). Meanwhile, the progression in whole genome sequencing has led to the utilization of an increasing number of reference genomes in SNP calling processes. This study utilized RAD-seq data from 242 individuals of Engelhardia roxburghiana, a tropical tree of the walnut family (Juglandaceae), with SNP calling conducted using the STACKS pipeline...
May 2, 2024: Plant Science: An International Journal of Experimental Plant Biology
https://read.qxmd.com/read/38704093/mito-end-3-efficacy-of-avelumab-immunotherapy-according-to-molecular-profiling-in-first-line-endometrial-cancer-therapy
#36
JOURNAL ARTICLE
S Pignata, D Califano, D Lorusso, L Arenare, M Bartoletti, U De Giorgi, C Andreetta, C Pisano, G Scambia, D Lombardi, A Farolfi, S Cinieri, A Passarelli, V Salutari, C De Angelis, C Mignogna, D Priolo, E D Capoluongo, S Tamberi, G L Scaglione, V Arcangeli, R De Cecio, G Scognamiglio, F Greco, A Spina, M Turinetto, D Russo, V Carbone, C Casartelli, C Schettino, F Perrone
BACKGROUND: Immunotherapy combined with chemotherapy significantly improves progression-free survival compared to first-line chemotherapy alone in advanced endometrial cancer, with a much larger effect size in microsatellite-instability high (MSI-H) cases. New biomarkers might help to select patients that may have benefit among those with a microsatellite-stable (MSS) tumor. METHODS: In a pre-planned translational analysis of the MITO END-3 trial, we assessed the significance of genomic abnormalities in patients randomized to standard carboplatin/paclitaxel without or with avelumab...
May 2, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/38704030/acute-promyelocytic-leukemia-with-torque-teno-mini-virus-ttmv-rara-fusion-an-approach-to-screening-and-diagnosis
#37
JOURNAL ARTICLE
Harrison K Tsai, Mark F Sabbagh, Meagan Montesion, Erik A Williams, Arnaldo Arbini, Daniel R Boué, Emily M Harris, Franziska Wachter, Leslie Grimmett, Andrew E Place, Fabienne Lucas, Valentina Nardi, Annette S Kim, Carlo Brugnara, Barbara Degar, Jessica Pollard, Marian H Harris, Jacob R Bledsoe
Acute promyelocytic leukemia (APL) with variant RARA translocation is linked to over 15 partner genes. Recent publications encompassing six cases have expanded the spectrum of RARA partners to torque teno mini virus (TTMV). This entity is likely under-recognized due to lack of clinician and pathologist familiarity, inability to detect the fusion using routine testing modalities, and informatic challenges in its recognition within next-generation sequencing (NGS) data. We describe a clinicopathologic approach and provide necessary tools to screen and diagnose APL with TTMV::RARA using existing clinical DNA or RNA-based NGS assays, which led to identification of four cases, all without other known cytogenetic/molecular drivers...
May 2, 2024: Modern Pathology
https://read.qxmd.com/read/38703036/primary-mitochondrial-disorders-and-mimics-insights-from-a-large-french-cohort
#38
JOURNAL ARTICLE
Cécile Rouzier, Emmanuelle Pion, Annabelle Chaussenot, Céline Bris, Samira Ait-El-Mkadem Saadi, Valérie Desquiret-Dumas, Naïg Gueguen, Konstantina Fragaki, Patrizia Amati-Bonneau, Giulia Barcia, Pauline Gaignard, Julie Steffann, Alessandra Pennisi, Jean-Paul Bonnefont, Elise Lebigot, Sylvie Bannwarth, Bruno Francou, Benoit Rucheton, Damien Sternberg, Marie-Laure Martin-Negrier, Aurélien Trimouille, Gaëlle Hardy, Stéphane Allouche, Cécile Acquaviva-Bourdain, Cécile Pagan, Anne-Sophie Lebre, Pascal Reynier, Mireille Cossee, Shahram Attarian, Véronique Paquis-Flucklinger, Vincent Procaccio
OBJECTIVE: The objective of this study was to evaluate the implementation of NGS within the French mitochondrial network, MitoDiag, from targeted gene panels to whole exome sequencing (WES) or whole genome sequencing (WGS) focusing on mitochondrial nuclear-encoded genes. METHODS: Over 2000 patients suspected of Primary Mitochondrial Diseases (PMD) were sequenced by either targeted gene panels, WES or WGS within MitoDiag. We described the clinical, biochemical, and molecular data of 397 genetically confirmed patients, comprising 294 children and 103 adults, carrying pathogenic or likely pathogenic variants in nuclear-encoded genes...
May 4, 2024: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/38702429/utility-of-next-generation-sequencing-in-paediatric-neurological-disorders-experience-from-south-africa
#39
JOURNAL ARTICLE
Magriet van Niekerk, Shahida Moosa, Ronald van Toorn, Regan Solomons
Next generation sequencing (NGS)-based tests have become routine first-line investigative modalities in paediatric neurology clinics in many high-income countries (HICs). Studies from these countries show that these tests are both cost-effective and reliable in diagnosing many complex childhood neurological diseases. However, NGS-based testing in low-and middle-income countries (LMICs) is limited due to affordability constraints. The primary objective of this study was to evaluate the diagnostic yield and impact of targeted gene panel sequencing in a selected paediatric cohort attending a tertiary paediatric neurology clinic in the Western Cape Province of South Africa...
May 3, 2024: European Journal of Human Genetics: EJHG
https://read.qxmd.com/read/38701358/cost-effectiveness-of-genetic-testing-of-endocrine-tumor-patients-using-a-comprehensive-hereditary-cancer-gene-panel
#40
JOURNAL ARTICLE
Attila Patócs, Petra Nagy, János Papp, Anikó Bozsik, Bálint Antal, Vince Kornél Grolmusz, Tímea Pócza, Henriett Butz
INTRODUCTION: Heterogenous clinical manifestations, overlapping phenotypes and complex genetic backgrounds are common in patients with endocrine tumors. There are no comprehensive recommendations for genetic testing and counselling of these patients compared to other hereditary cancer syndromes. The application of multigene panel testing is common in clinical genetic laboratories, but their performance for patients with endocrine tumors has not been assessed. METHODS: As a national reference center, we prospectively tested the diagnostic utility and cost-efficiency of a multigene panel covering 113 genes representing genetic susceptibility for solid tumors...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
keyword
keyword
22756
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.